| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology and the University of Pennsylvania Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6076 [Z-K. P., G. I., Y. P.] and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 [D. P.]
We have shown previously that Listeria monocytogenes, a gram-positive, facultative intracellular bacterium, is a potent vector for targeting tumor-specific antigens to the immune system. After parenteral administration, we observed protection against both renal and colorectal mouse tumors and regression of established renal tumors. In the present study, we have exploited the fact that the normal route of infection of this organism is through the gut. We show that an L. monocytogenes recombinant that expresses a model tumor antigen is an effective cancer immunotherapeutic agent when delivered orally in that it causes regression of established, macroscopic mouse renal and colorectal tumors expressing the same antigen.
1 Supported in part by NIH Grant GM31841 to Y. P., who is also the recipient of an ACS Faculty Research Award.
2 To whom requests for reprints should be addressed, at University of Pennsylvania Medical Center, Department of Microbiology, 209 Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104-6076.
Received 8/ 7/95. Accepted 9/18/95.
This article has been cited by other articles:
![]() |
K. Yoshimura, L. S. Laird, C. Y. Chia, K. F. Meckel, J. E. Slansky, J. M. Thompson, A. Jain, D. M. Pardoll, and R. D. Schulick Live Attenuated Listeria Monocytogenes Effectively Treats Hepatic Colorectal Cancer Metastases and Is Strongly Enhanced by Depletion of Regulatory T Cells Cancer Res., October 15, 2007; 67(20): 10058 - 10066. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, M. Zhang, Z. Li, and F. R. Frankel Vaginal Protection and Immunity after Oral Immunization of Mice with a Novel Vaccine Strain of Listeria monocytogenes Expressing Human Immunodeficiency Virus Type 1 gag. J. Virol., September 1, 2006; 80(18): 8880 - 8890. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Laheru, D. M. Pardoll, and E. M. Jaffee Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology Mol. Cancer Ther., November 1, 2005; 4(11): 1645 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Sewell, V. Shahabi, G. R. Gunn III, Z.-K. Pan, M. E. Dominiecki, and Y. Paterson Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7 Cancer Res., December 15, 2004; 64(24): 8821 - 8825. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Peng, S. F. Hussain, and Y. Paterson The Ability of Two Listeria monocytogenes Vaccines Targeting Human Papillomavirus-16 E7 to Induce an Antitumor Response Correlates with Myeloid Dendritic Cell Function J. Immunol., May 15, 2004; 172(10): 6030 - 6038. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Sewell, D. Douven, Z.-K. Pan, A. Rodriguez, and Y. Paterson Regression of HPV-Positive Tumors Treated With a New Listeria monocytogenes Vaccine Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 92 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ercolini, J.-P. H. Machiels, Y. C. Chen, J. E. Slansky, M. Giedlen, R. T. Reilly, and E. M. Jaffee Identification and Characterization of the Immunodominant Rat HER-2/neu MHC Class I Epitope Presented by Spontaneous Mammary Tumors from HER-2/neu-Transgenic Mice J. Immunol., April 15, 2003; 170(8): 4273 - 4280. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Liau, E. R. Jensen, T. J. Kremen, S. K. Odesa, S. N. Sykes, M. C. Soung, J. F. Miller, and J. M. Bronstein Tumor Immunity within the Central Nervous System Stimulated by Recombinant Listeria monocytogenes Vaccination Cancer Res., April 1, 2002; 62(8): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Gunn, A. Zubair, C. Peters, Z.-K. Pan, T.-C. Wu, and Y. Paterson Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16 J. Immunol., December 1, 2001; 167(11): 6471 - 6479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vazquez-Boland, M. Kuhn, P. Berche, T. Chakraborty, G. Dominguez-Bernal, W. Goebel, B. Gonzalez-Zorn, J. Wehland, and J. Kreft Listeria Pathogenesis and Molecular Virulence Determinants Clin. Microbiol. Rev., July 1, 2001; 14(3): 584 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pope, S.-K. Kim, A. Marzo, K. Williams, J. Jiang, H. Shen, and L. Lefrancois Organ-Specific Regulation of the CD8 T Cell Response to Listeria monocytogenes Infection J. Immunol., March 1, 2001; 166(5): 3402 - 3409. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Reilly, M. B. C. Gottlieb, A. M. Ercolini, J.-P. H. Machiels, C. E. Kane, F. I. Okoye, W. J. Muller, K. H. Dixon, and E. M. Jaffee HER-2/neu Is a Tumor Rejection Target in Tolerized HER-2/neu Transgenic Mice Cancer Res., July 1, 2000; 60(13): 3569 - 3576. [Abstract] [Full Text] |
||||
![]() |
Z.-K. Pan, L. M. Weiskirch, and Y. Paterson Regression of Established B16F10 Melanoma with a Recombinant Listeria monocytogenes Vaccine Cancer Res., October 1, 1999; 59(20): 5264 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Ochsenbein, U. Karrer, P. Klenerman, A. Althage, A. Ciurea, H. Shen, J. F. Miller, J. L. Whitton, H. Hengartner, and R. M. Zinkernagel A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria PNAS, August 3, 1999; 96(16): 9293 - 9298. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.R.J. Evans and S.B. Kaye Vaccine therapy for cancer—fact or fiction? QJM, June 1, 1999; 92(6): 299 - 307. [Full Text] [PDF] |
||||
![]() |
P. Paglia, E. Medina, I. Arioli, C. A. Guzman, and M. P. Colombo Gene Transfer in Dendritic Cells, Induced by Oral DNA Vaccination With Salmonella typhimurium, Results in Protective Immunity Against a Murine Fibrosarcoma Blood, November 1, 1998; 92(9): 3172 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Yeung, R. S. Gieni, D. T. Umetsu, and R. H. DeKruyff Heat-Killed Listeria monocytogenes as an Adjuvant Converts Established Murine Th2-Dominated Immune Responses into Th1-Dominated Responses J. Immunol., October 15, 1998; 161(8): 4146 - 4152. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |